DNA sequence encodes the position of DNA supercoils
Abstract
The three-dimensional organization of DNA is increasingly understood to play a decisive role in vital cellular processes. Many studies focus on the role of DNA-packaging proteins, crowding, and confinement in arranging chromatin, but structural information might also be directly encoded in bare DNA itself. Here we visualize plectonemes (extended intertwined DNA structures formed upon supercoiling) on individual DNA molecules. Remarkably, our experiments show that the DNA sequence directly encodes the structure of supercoiled DNA by pinning plectonemes at specific sequences. We develop a physical model that predicts that sequence-dependent intrinsic curvature is the key determinant of pinning strength and demonstrate this simple model provides very good agreement with the data. Analysis of several prokaryotic genomes indicates that plectonemes localize directly upstream of promoters, which we experimentaly confirm for selected promotor sequences. Our findings reveal a hidden code in the genome that helps to spatially organize the chromosomal DNA.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files. The previously published genome data for E. coli used in Figure 4B can be accessed here http://regulondb.ccg.unam.mx/menu/download/datasets/files/PromoterSet.txt; V. cholerae here http://www.pnas.org/highwire/filestream/618514/field_highwire_adjunct_files/2/pnas.1500203112.sd02.xlsx; B. methanolicus here https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342826/bin/12864_2015_1239_MOESM2_ESM.xlsx; M. tuberculosis here https://ars.els-cdn.com/content/image/1-s2.0-S2211124713006153-mmc2.xlsx; and C. crescentus here https://doi.org/10.1371/journal.pgen.1004831.s012. The previously published genome data for D. melanogaster, C. elegans, A. thaliana, S. cerevisiae, and S. pombe used in Figure 4E can be accessed using the Eukaryotic Promotor Database (https://epd.vital-it.ch).
-
Whole genome sequence data: E. ColiNCBI Genome, NC_000913.3.
-
Whole genome sequence data: S. cerevisiase (Chr I)NCBI Nucleotide, NC_001133.9.
-
Whole genome sequence data: S. cerevisiase (Chr II)NCBI Nucleotide, NC_001134.8.
-
Whole genome sequence data: S. cerevisiase (Chr III)NCBI Nucleotide, NC_001135.5.
-
Whole genome sequence data: S. cerevisiase (Chr IV)NCBI Nucleotide, NC_001136.10.
-
Whole genome sequence data: S. cerevisiase (Chr V)NCBI Nucleotide, NC_001137.3.
-
Whole genome sequence data: S. cerevisiase (Chr VI)NCBI Nucleotide, NC_001138.5.
-
Whole genome sequence data: S. cerevisiase (Chr VII)NCBI Nucleotide, NC_001139.9.
-
Whole genome sequence data: S. cerevisiase (Chr VIII)NCBI Nucleotide, NC_001140.6.
-
Whole genome sequence data: S. cerevisiase (Chr IX)NCBI Nucleotide, NC_001141.2.
-
Whole genome sequence data: S. cerevisiase (Chr X)NCBI Nucleotide, NC_001142.9.
-
Whole genome sequence data: S. cerevisiase (Chr XI)NCBI Nucleotide, NC_001143.9.
-
Whole genome sequence data: S. cerevisiase (Chr XII)NCBI Nucleotide, NC_001144.5.
-
Whole genome sequence data: S. cerevisiase (Chr XIII)NCBI Nucleotide, NC_001145.3.
-
Whole genome sequence data: S. cerevisiase (Chr XIV)NCBI Nucleotide, NC_001146.8.
-
Whole genome sequence data: S. cerevisiase (Chr XV)NCBI Nucleotide, NC_001147.6.
-
Whole genome sequence data: S. cerevisiase (Chr XVI)NCBI Nucleotide, NC_001148.4.
-
Whole genome sequence data: S. cerevisiaseNCBI Nucleotide, NC_001224.1.
Article and author information
Author details
Funding
H2020 European Research Council (669598)
- Cees Dekker
The Netherlands Organization for Scientific Research (the Frontiers of Nanoscience program)
- Elio Abbondanzieri
H2020 European Research Council (304284)
- Elio Abbondanzieri
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2018, Kim et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 6,473
- views
-
- 951
- downloads
-
- 71
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Chromosomes and Gene Expression
- Neuroscience
Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.
-
- Biochemistry and Chemical Biology
- Chromosomes and Gene Expression
The mRNA 5'-cap structure removal by the decapping enzyme DCP2 is a critical step in gene regulation. While DCP2 is the catalytic subunit in the decapping complex, its activity is strongly enhanced by multiple factors, particularly DCP1, which is the major activator in yeast. However, the precise role of DCP1 in metazoans has yet to be fully elucidated. Moreover, in humans, the specific biological functions of the two DCP1 paralogs, DCP1a and DCP1b, remain largely unknown. To investigate the role of human DCP1, we generated cell lines that were deficient in DCP1a, DCP1b, or both to evaluate the importance of DCP1 in the decapping machinery. Our results highlight the importance of human DCP1 in decapping process and show that the EVH1 domain of DCP1 enhances the mRNA-binding affinity of DCP2. Transcriptome and metabolome analyses outline the distinct functions of DCP1a and DCP1b in human cells, regulating specific endogenous mRNA targets and biological processes. Overall, our findings provide insights into the molecular mechanism of human DCP1 in mRNA decapping and shed light on the distinct functions of its paralogs.